To compare the efficacy and safety of Herbavate vs. the conventional steroid therapy in the management of hand dermatitis.
- Conditions
- Health Condition 1: null- Hand Dermatitis
- Registration Number
- CTRI/2009/091/000212
- Lead Sponsor
- Troikaa Pharmaceuticals Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
1.18 years of age or older;
2.Have mild to moderate hand dermatitis, according to the Investigator Global Assessment (score2-3);
3.Be generally healthy, as determined by brief medical history;
4.Be capable of understanding and signing the consent form.
1.Have clinically relevant allergic or irritant contact dermatitis and the inability to avoid exposure;
2.Have severe dermatitis according to the Investigator Global Assessment (score 4);
3.Have severe vesiculation or bullae;
4.Have a history of psoriasis, contact urticaria, and/or pustular diseases;
5.Have had therapy with potent topical corticosteroids within one month prior to enrollment;
6.Have used systemic treatment with oral retinoids, corticosteroids, or with PUVA within the 8 week period prior to the beginning of the study;
7.Have a history or current evidence of a chronic or infectious skin disease
8.Are pregnant or lactating, or women not using highly effective contraception;
9.Current participation in any other interventional clinical trial;
10.Patients who have received treatment with any nonmarketed drug substance (i.e. an agent which has not yet been made available for clinical use) within 4 weeks prior to randomisation; and
11.Patient known or, in the opinion of the investigator, is unlikely to comply with the Clinical Study Protocol (e.g. alcoholism, drug dependency, or psychotic state).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method